Lai Wang
CIK 1852291 · President, Global Head of R&D · last filed 2026-06-10
Lai Wang is a President, Global Head of R&D who has filed 28 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider sold $368.2K of ONC on Jun 10, 2026. Across all open-market trades the lifetime net is −$9.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$10.6K
2
28
-$9.18M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ONC | President, Global Head of R&D | 40 | $264.48 | $10.6K | -$5.97M | 12 | 2026-06-10 |
| BeOne Medicines Ltd. (BGNE) Delisted | Global Head of R&D | 1,717,885 | $184.71 | $317.31M | -$3.21M | 16 | 2024-10-01 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | ONC | Sell (S) | −1,367 | -$368.2K | EDGAR |
| 2026-03-10 | ONC | Grant (A) | +167,635 | $0 | EDGAR |
| 2026-01-05 | ONC | Grant (A) | +427,895 | $0 | EDGAR |
| 2025-09-11 | ONC | Sell (S) | −5,000 | -$1.75M | EDGAR |
| 2025-07-31 | ONC | Sell (S) | −4,300 | -$1.30M | EDGAR |
| 2025-07-22 | ONC | Sell (S) | −700 | -$210.0K | EDGAR |
| 2025-06-25 | ONC | Sell (S) | −1,028 | -$267.3K | EDGAR |
| 2025-06-18 | ONC | Sell (S) | −1,647 | -$431.7K | EDGAR |
| 2025-06-12 | ONC | Grant (A) | +86,359 | $0 | EDGAR |
| 2025-06-10 | ONC | Sell (S) | −1,402 | -$353.9K | EDGAR |